What is remdesivir? Gilead Sciences drug reportedly shows promise treating coronavirus

What is remdesivir? Gilead Sciences drug reportedly shows promise treating coronavirus

A Gilead Sciences antiviral drug is reportedly showing promise for treatment of the coronavirus.

Remdesivir is causing "rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week" in patients at a Chicago hospital, medical site STAT reported.

The story has led to a surge in stock futures Friday and a jump in Gilead's stock price, which rose 10.8% in pre-market trading to $84.80.

"The entire world has been waiting for results from Gilead’s clinical trials, and positive results would likely lead to fast approvals by the Food and Drug Administration and other regulatory agencies," STAT reported. "If safe and effective, it could become the first approved treatment against the disease."

Remdesivir is one of numerous drugs under development to treat or cure the coronavirus. Clinical trials are conducted to ensure safety and efficacy, and there's no guarantee the Chicago hospital's results will be replicated elsewhere.

The results came from the University of Chicago Medicine, which is participating in two Gilead clinical trials involving 2,400 severe cases at 152 sites and 1,600 moderate cases at 169 sites, according to STAT. The University of Chicago data covered 125 people infected with COVID-19, including 113 severe cases, all of whom are being given daily doses.

STAT reported the news based on a video of trial leaders discussing the early results.

Meat shortage 2020::Coronavirus has led Smithfield, other plants to close, farmers to dump milk

Coronavirus auto insurance refunds:Here's what you need to know

Evercore ISI drug industry analyst Umer Raffat wrote late Thursday in a research note that it's "not a silver bullet" but there's reason to be "cautiously optimistic."

Medical professionals have had high hopes for remdesivir since the coronavirus pandemic began.

In this March 2020 photo provided by Gilead Sciences, rubber stoppers are placed onto filled vials of the investigational drug remdesivir at a Gilead manufacturing site in the United States.

Other studies have shown promising results, as well, albeit with fewer patients.

The New England Journal of Medicine on Friday published the results of a 10-day study involving 53 "quite severe" patients in which 68% showed "clinical improvement," 47% were discharged before the study was completed and 13% died, according to UBS analyst Navin Jacob.

"Ultimately if remdesivir does prove effective, we think it is likely to be best suited for treating hospitalized patients and unlikely as a prophylactic therapy given some unknowns on safety," Jacob wrote Monday in a research note. "Nonetheless an effective treatment that reduces the need for ICU beds, speeds up discharges, & reduces mortality could hypothetically provide relief to the (health care) system."

Remdesivir, the result of more than a decade of Gilead research, has been tested for multiple potential applications in recent years. The company tested the drug as a treatment for Ebola in west Africa in 2014. It has also been tested as a treatment of SARS and for hepatitis C.

Gilead representatives were not immediately available to comment Friday.

If remdesivir were approved by the FDA, Gilead hopes to start manufacturing quickly.

"In anticipation of potential future needs, we have accelerated manufacturing timelines to increase our available supply as rapidly as possible," Gilead says in a fact sheet about the drug. "We are doing this before knowing whether remdesivir will be determined to be safe and effective to treat patients with COVID-19."

Follow USA TODAY reporter Nathan Bomey on Twitter @NathanBomey.

Source: https://www.usatoday.com/story/money/2020/04/17/remdesivir-coronavirus-drug-gilead-sciences-covid-19-treatment/5150793002/

News Related


Trump’s ‘mission accomplished’ moment is premature and deadly. We have not defeated COVID.

Desperate for crowds and adoration, Trump has put his most fervent supporters at risk of getting a deadly disease. Future historians will be astonished. Read more »

NFLPA president JC Tretter says NFL is putting season, players at risk with its coronavirus approach

NFL Players Association president JC Tretter said Tuesday the NFL is putting the 2020 season at risk with its coronavirus approach, calling on the league to better “prioritize player safety.” “Like many other... Read more »

Brazilian President Jair Bolsonaro says he tested positive for the coronavirus

RIO DE JANEIRO (AP) — Brazil’s President Jair Bolsonaro says he has tested positive for COVID-19 after months of downplaying the virus’ severity. Bolsonaro confirmed the test results while wearing a mask and... Read more »

Venice Film Festival forges ahead amid COVID-19 pandemic with reduced lineup

The show will go on for the Venice Film Festival in September, but with a few modifications due to the COVID-19 pandemic. Organizers said Tuesday that they are pushing forward with plans for... Read more »

Amtrak offers buy-one, get-one promotion on its sleeper trains amid COVID-19 — with a catch

Amtrak wants you to have sweet dreams the next time you travel — so much so that it’s sweetening the deal on its sleeper “roomettes.” The rail service is offering a buy-one-get-one-free discount... Read more »

Florida teen treated with hydroxychloroquine at home before dying of COVID-19, report says

FORT MEYERS, Fla. – The family of a 17-year-old Florida girl who died last month from COVID-19 treated her symptoms at home for nearly a week before taking her to a hospital, a... Read more »

Mookie Betts worried MLB coronavirus testing woes could prevent him from ever playing for Dodgers

During nearly four months away from the game, Mookie Betts said he “stayed away from baseball to keep myself sane.” It’s not hard to understand why. The 2018 American League Most Valuable Player... Read more »

Tom Hanks doesn’t get ‘how common sense has somehow been put into question’ with coronavirus

Read more »

Can Gov. DeSantis force Florida schools to reopen amid the coronavirus pandemic? Some school leaders seem doubtful.

PALM BEACH, Fla. — As concern about the state order spread online, some school leaders said: Not so fast. As Florida educators puzzle over how to start the new academic year, Gov. Ron... Read more »

Texas surpasses 200,000 coronavirus cases after 4th of July holiday weekend

AUSTIN, Texas – Texas reached 200,000 total COVID-19 cases Monday, just 17 days after crossing the 100,000 threshold, a figure that took the state nearly four months to hit. The grim milestone came... Read more »